ST2-ANTIGENBINDENDE PROTEINE

European patent · EP2850103 · In force

Register entry

Publication number
EP2850103
Application number
EP13790269
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
May 17, 2013
Published
Mar 25, 2015
Granted
Jul 22, 2020
Protection ends at the latest
May 16, 2033
Next annual fee due
May 31, 2027
IPC classes
C07K 16/28 (2006.01)
Priority
US 201261649147 P 18.05.2012
US 201361792619 P 15.03.2013
PCT application
PCT/US2013/041656 17.05.2013
PCT publication
WO2013/173761 21.11.2013
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Jun 1, 2026

    Change

    Published in Swissreg on 01.06.2026

  2. Jun 1, 2025

    Change

    Published in Swissreg on 01.06.2025

  3. Jun 2, 2024

    Change

    Published in Swissreg on 02.06.2024

  4. Jun 1, 2023

    Change

    Published in Swissreg on 01.06.2023

  5. Jul 22, 2020

    Granted

    Published in Swissreg on 22.07.2020

Parties

Holder

Amgen Inc.

One Amgen Center Drive, Thousand Oaks, California 91320-1799, US

Inventor

COMEAU, Michael R.

Bainbridge Island, Washington 98110, US

LIM, Ai Ching

Mercer Island, Washington 98040, US

SHI, Donghui

Thousand Oaks, California 91362, US

WANG, Zhulun

Palo Alto, California 94306, US

FOLTZ, Ian

Burnaby, BC V5A 4B9, CA

SMITH, Dirk E.

Bainbridge Island, Washington 98110, US

MIN, Xiaoshan

Burlingame, California 94010, US

KETCHEM, Randal R.

Snohomish, Washington 98296, US

KING, Chadwick T.

North Vancouver, BC V7L 3T5, CA

CLARK, Rutilio

Bainbridge Island, Washington 98110, US

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.